ArticleFrontiers in oncology2024

Exploration of the value of concurrent chemotherapy for T2N1 nasopharyngeal carcinoma under intensity modulated radiotherapy mode.

Kai Liao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.